Bertolani A, Ravasio R, Raimondo P, Jommi C. The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study. Grhta [Internet]. 2022 Jul. 18 [cited 2024 Dec. 4];9(1):73-81. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2415